Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

56.21
-0.5500-0.97%
Post-market: 56.210.00000.00%19:30 EDT
Volume:2.85M
Turnover:159.41M
Market Cap:32.43B
PE:30.15
High:56.71
Open:56.57
Low:55.13
Close:56.76
52wk High:64.38
52wk Low:35.23
Shares:576.94M
Float Shares:392.53M
Volume Ratio:0.92
T/O Rate:0.73%
Dividend:0.91
Dividend Rate:1.62%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:4.75
PE(LYR):31.55

Loading ...

Jul 16, 2021

Major Issues Report

8-K - Current report
Jul 15, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence